2007 outlook for US health care provider sector viewed by Ernst & Young

15 January 2007

In 2007, the convergence of market pressures, public policy developments and cost recovery concerns in the US health care provider sector will drive momentum for wider adoption of electronic records, improved efficiencies, greater transparency and new metrics for quality care, according to professional services company Ernst & Young's health care provider practice.

"Health care is operating under a growing strain to serve more patients, cut costs and maintain - and demonstrate - quality of care," said Dee Balle, America's provider care sector leader at Ernst & Young. "We are likely to see more focus on a transformation in business processes and operations in the coming year as hospitals and hospital networks confront these challenges. And the leaders - those who get out front - will raise the bar and create a more competitive environment among health care providers," she added.

According to Ernst & Young' study, among the key issues that will shape 2007 for the USA's health care provider industry are:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight